Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Patient-specific and Gene-corrected Induced Pluripotent Stem Cell-derived Endothelial Cells Elucidate Single-cell Phenotype of Pulmonary Veno-occlusive Disease

ABSTRACT: Patient-specific and Gene-corrected Induced Pluripotent Stem Cell-derived Endothelial Cells Elucidate Single-cell Phenotype of Pulmonary Veno-occlusive Disease

PROVIDER: PRJNA891628 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR21943907_1.fastq.gz	Fastqsanger.gz
	SRR21943907_2.fastq.gz	Fastqsanger.gz
	SRR21943908_1.fastq.gz	Fastqsanger.gz
	SRR21943908_2.fastq.gz	Fastqsanger.gz
	SRR21943909_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

Patient-specific and Gene-corrected Induced Pluripotent Stem Cell-derived Endothelial Cells Elucidate Single-cell Phenotype of Pulmonary Veno-occlusive Disease

Project description:PVOD is a rare form of pulmonary hypertension characterized by the preferential remodeling of the pulmonary venules. Hereditary PVOD is caused by biallelic variants of the EIF2AK4 gene. Three PVOD patients who carried the compound heterozygous variants of EIF2AK4 and two healthy controls were recruited and iPSCs were generated from human peripheral blood mononuclear cells (PBMCs). The EIF2AK4 c.2965C>T variant (PVOD#1), c.3460A>T variant (PVOD#2) and c.4832_4833insAAAG variant (PVOD#3) were corrected by CRISPR/Cas9 in PVOD-iPSCs to generate isogenic controls and gene-corrected-iPSCs (GC-iPSCs). PVOD-iPSC-ECs exhibited a decrease in GCN2 protein and mRNA expression, when compared to control and GC-ECs. PVOD-ECs exhibited an abnormal endothelial cell phenotype featured by excessive proliferation and angiogenesis. The abnormal phenotype of PVOD-ECs was normalized by AKT inhibitors AZD5363 and MK2206. These findings help elucidate the underlying molecular mechanism of PVOD in humans, and identify promising therapeutic drugs for treating the disease

2022-10-21 | GSE215978 | GEO

Patient-specific and gene-corrected induced pluripotent stem cell-derived endothelial cells elucidate single-cell phenotype of pulmonary veno-occlusive disease.

Project description:Pulmonary veno-occlusive disease (PVOD) is a rare form of pulmonary hypertension characterized by the preferential remodeling of the pulmonary venules. Hereditary PVOD is caused by biallelic variants of the EIF2AK4 gene. Three PVOD patients who carried the compound heterozygous variants of EIF2AK4 and two healthy controls were recruited and induced pluripotent stem cells (iPSCs) were generated from human peripheral blood mononuclear cells (PBMCs). The EIF2AK4 c.2965C>T variant (PVOD#1), c.3460A>T variant (PVOD#2), and c.4832_4833insAAAG variant (PVOD#3) were corrected by CRISPR-Cas9 in PVOD-iPSCs to generate isogenic controls and gene-corrected-iPSCs (GC-iPSCs). PVOD-iPSC-endothelial cells (ECs) exhibited a decrease in GCN2 protein and mRNA expression when compared with control and GC-ECs. PVOD-ECs exhibited an abnormal EC phenotype featured by excessive proliferation and angiogenesis. The abnormal phenotype of PVOD-ECs was normalized by protein kinase B inhibitors AZD5363 and MK2206. These findings help elucidate the underlying molecular mechanism of PVOD in humans and to identify promising therapeutic drugs for treating the disease.

| S-EPMC9768576 | biostudies-literature

Differential Expression Profile of MicroRNAs and Tight Junction in Lung Tissue of Rat with Mitomycin-C Induced Pulmonary Veno-Occlusive Disease

Project description:Pulmonary veno-occlusive disease (PVOD) is characterized by increased pulmonary vascular resistance. Currently, there is a lack of effective treatment. It is of great significance to explore molecular targets for treatment of the disease. This study investigated the differentially expressed profile of miRNAs and tight junction in the lung tissue of rats with mitomycin-C induced PVOD.

2021-11-30 | GSE189080 | GEO

Essential role of Protein kinase R in the pathogenesis of pulmonary veno-occlusive disease

Project description:Pulmonary veno-occlusive disease (PVOD) is a rare and severe form of pulmonary arterial hypertension, characterized by progressive obstruction of small pulmonary vessels and a lack of effective therapeutic options. Our previous research, utilizing a mitomycin C (MMC)-induced rat model, demonstrated that activation of the integrated stress response (ISR) via protein kinase R (PKR) is a critical driver of endothelial dysfunction and pulmonary vascular remodeling. However, it remains unclear whether PKR is the sole mediator of ISR activation and the pathogenesis of PVOD under the MMC treatment. In this study, we administered the same dose of MMC used in rats to control (Ctrl) and PKR knockout (KO) mice. Consistent with observations in rats, Ctrl mice exhibited ISR activation in the vascular endothelium and rapidly developed vascular remodeling in both arteries and veins following MMC treatment. In contrast, KO mice showed no evidence of ISR activation or vascular remodeling under same conditions. Proteomic analysis revealed that the PKR-ISR axis perturbs proteostasis in Ctrl mice but not in KO mice. These findings highlight the essential role of PKR-mediated ISR activation and the disruption of proteostasis in the pathogenesis of PVOD, placing PKR as a promising therapeutic target for this disease.

2025-08-11 | PXD066782 | Pride

High-throughput error corrected Nanopore single cell transcriptome sequencing

Project description:High-throughput error corrected Nanopore single cell transcriptome sequencing

| PRJNA541014 | ENA

Parallel Single B Cell Transcriptomics to Elucidate Pig B Cell Repertoire

Project description:Parallel Single B Cell Transcriptomics to Elucidate Pig B Cell Repertoire

| PRJNA1123690 | ENA

A Polygenic Score for Acute Vaso-Occlusive Pain in Pediatric Sickle Cell Disease

Project description:A Polygenic Score for Acute Vaso-Occlusive Pain in Pediatric Sickle Cell Disease

| PRJNA739768 | ENA

A Polygenic Score for Acute Vaso-Occlusive Pain in Pediatric Sickle Cell Disease

Project description:A Polygenic Score for Acute Vaso-Occlusive Pain in Pediatric Sickle Cell Disease

| PRJNA739769 | ENA

Gene expression in occlusive vein grafts following CABG of human

Project description:To further understand the mechanism approach to occlusive vein grafts, we have employed RNA-seq to identify key genes in occlusive venin grafts following CABG in human. The occluded vein graft and intraoperative spare great saphenous vein of patients undergoing clinical re-coronary artery bypass grafting were obtained for RNA-seq. The sequencing results were cleaned and bioinformatics annlysis was conducted by using WGCNA and a variety of online databases and software. The key genes or proteins affecting the occurrence of vein graft restenosis were screened out(ITGB2), and the expression level of the target genes or proteins was verified by real-time PCR and Western blot. And to further learn the effect of ITGB2 in human primary venous smooth muscle cells, ITGB2 gene was silenced by SiRNA. The effect of ITGB2 silencing on proliferation, migration and invasion of venous smooth muscle cells after PDGF-BB-stimulation were detected by Edu assay, scrathch experiment and transwell experiment. And Edu assay showed that ITGB2 silencing could inhibit the proliferation of PDGF-BB sitmulated smooth muscle cells. Scratch assay showed that ITGB2 silencing inhibited the migration of PDGF-BB stimulated smooth muscle cells. Transwell assay showed that ITGB2 silencing significantly inhibited the invasion of PDGF-BB stimulated smooth muscle cells. It is indicated that ITGB2 was the key gene in vein graft restenosis,and may be the potential treatment target in restenosis patients.

2024-01-17 | GSE241205 | GEO

Reversal of pulmonary veno-occlusive disease phenotypes by inhibition of the integrated stress response

Project description:Reversal of pulmonary veno-occlusive disease phenotypes by inhibition of the integrated stress response

| PRJNA954373 | ENA